-
The funnyman on how he made it from Tipton, Missouri, to Hollywood, and some of the best pop-up and ghost kitchens in the metro.
-
Children's Mercy Hospital led distribution for the newly approved age group but other providers anticipate turnout will ramp up as schools close for the summer.
-
Even as pharmaceutical companies announce high success rates in their most recent trials, life won't return to normal anytime soon.
-
An update on national and local coronavirus vaccine trials, and the latest on Alzheimer's research and therapies.
-
Traditional clinical trials often include white patients predominantly, but a diverse pool of participants can help make new vaccines more effective across demographics.
-
The trials had barely gotten underway when the AZ1222 vaccine developed by the University of Oxford and purchased by drug maker AstraZeneca was temporarily paused late last month.
-
Vaccination rates are lower than usual this year, especially in school districts still learning virtually. Now pediatricians are urging parents to bring their kids in for well-child checks and childhood immunizations.
-
The coronavirus isn’t running rampant through schools that have reopened. Health officials say that’s because with precautions, schools can operate safely.
-
AstraZeneca hopes to enroll 30,000 people in its Phase 3 trials in the United States. The KU/Children’s Mercy trial was looking to recruit 1,500 participants.
-
The numbers are headed in the wrong direction for an in-person start to the school year in many communities, and when buildings can reopen, it won't mean a return to pre-pandemic learning. Here's what the experts say to expect.
-
As the number of coronavirus cases continues to rise in Kansas and Missouri, potential COVID-19 vaccines are entering clinical trials in Kansas City and the rest of the country.
-
Jobless claims in Kansas and Missouri continue to soar and federal unemployment benefits are expiring, some residents of Kansas City's most dangerous neighborhoods could be eligible for a free Ring doorbell, and what we know about a possible COVID-19 vaccine.